Here's something only a handful of people are asking -
Could A.I. Bring About
the End of Disease?
- A.I. discovered a new treatment for multiple myeloma...in just 4 months.
- A.I. discovered a new treatment for liver cancer...in only 30 days.
- A.I. discovered a new treatment for childhood brain cancer...in just 24 hours.
Get the name of the small-cap Bristol-Myers, Eli Lilly, NVIDIA
and Bill Gates backed with over $5 billion below.
Here's something only
a handful of people are asking -
Could A.I. Bring About
the End of Disease?
- A.I. discovered a new treatment for
multiple myeloma...in just 4 months. - A.I. discovered a new treatment for
liver cancer...in only 30 days. - A.I. discovered a new treatment for
childhood brain cancer...in just 24 hours.
Get the name of the small-cap
Bristol-Myers, Eli Lilly, NVIDIA, and
Bill Gates backed with over
$5 billion below.
Dear Friend,
Do you see this pill... This one right here -
This pill helps fight liver cancer. It’s called Nex-a-var. It’s made by Bayer.
It took 11 years to develop it. And it cost $2.6 billion.
But thanks to a new breakthrough…
A new treatment for liver cancer was created in just 30 days.
Take brain cancer.
Survival rates for childhood brain cancer have not changed in 50 years.
But this new breakthrough found a potential new treatment in just 24 hours.
Take multiple myeloma.
The biotech industry has been working on this problem for 20 years.
But on December 22, 2022, a new treatment was found….
…in just 4 months.
That’s why scientists around the world are calling this breakthrough “the most important event in human history.”
And why CEOS of big tech companies are saying this breakthrough is, “more important than the discovery of fire and electricity.”
That’s because this new breakthrough is on the verge of changing what happens when you get a disease.
As former House Majority Leader Kevin McCarthy put it, “You know, there’s 10,000 diseases, and we only have 500 cures.”
Diseases like Liver Disease…Diabetes…Skin Cancer... You name it.
And what drug companies do is pick one disease from the list at a time and they try to create a drug that treats that one disease.
But there’s a problem with the system – the average drug takes 12 years and costs $2.6 billion to bring to market.
That’s why we’ve only invented 500 cures – to treat 10,000 diseases!
This New Breakthrough Could Mean the End of Disease!
But what makes this new breakthrough so unique is that it could mean the end of disease for the human species in the future.
And if that sounds like science fiction, consider this –
The largest names in business have invested billions of dollars into this small cap.
Bill Gates owns 7 million shares.
Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares.
BlackRock owns 5 million shares…
Vanguard owns 3 million shares…
And that’s on top of the 5-year partnership agreement they signed with Google.
The list goes on and on…
Never before has medical science moved into a new technology so quickly.
But big business isn’t the only one getting in on the act.
As the true power of this treatment begins to comes into focus, it’s become a national security issue for us and our NATO allies.
And that’s what makes this breakthrough so unique:
It’s not just about money anymore...
It’s about which country is going to lead in the future of medicine for the next fifty years.
That’s why “Bill 117-167” received bi-partisan support and was voted into law on August 9, 2022.
...For us to win the battle for the future, our entire government had to get behind this breakthrough.
This treatment will not just change medicine.
It has the potential to eliminate disease for our species.
And because of that, it could create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.
The current market capitalization is just $2 billion.
But we expect it to soar to more than twice what Facebook is worth, or $1.5 Trillion, by 2030.
That’s because Wall Street sees the potential of Gilead Sciences.
Early investors in Gilead, one of the pioneers of biological medicine, earned as much as 36,996% on their money.
And that was off the back of one drug Gilead created: Viread. Viread is used to treat HIV patients.
This revolutionary new treatment has the potential to treat all 10,000 diseases, not just one.
In a moment, I’ll take you behind the scenes and share what I know about the breakthrough that’s at the forefront of this medical revolution, and who makes it.
Most importantly, I’ll explain how you can personally profit from it.
Once you see how this technology works you’ll understand why people, companies and governments around the world are rushing to get in on it.
But first, it’s important for you to know who I am and why I am so confident about this unique opportunity.
Dear Friend,
Do you see this pill...
This one right here -
This pill helps fight liver cancer. It’s called Nex-a-var. It’s made by Bayer.
It took 11 years to develop it. And it cost $2.6 billion.
But thanks to a new breakthrough…
A new treatment for liver cancer was created in just 30 days.
Take brain cancer.
Survival rates for childhood brain cancer have not changed in 50 years.
But this new breakthrough found a potential new treatment in just 24 hours.
Take multiple myeloma.
The biotech industry has been working on this problem for 20 years.
But on December 22, 2022, a new treatment was found….
…in just 4 months.
That’s why scientists around the world are calling this breakthrough “the most important event in human history”
And why CEOS of big tech companies are saying this breakthrough is, “more important than the discovery of fire and electricity.”
That’s because this new breakthrough is on the verge of changing what happens when you get a disease.
As former House Majority Leader Kevin McCarthy put it, “You know, there’s 10,000 diseases, and we only have 500 cures.”
Diseases like Liver Disease…Diabetes…Skin Cancer... You name it.
And what drug companies do is pick one disease from the list at a time and they try to create a drug that treats that one disease.
But there’s a problem with the system – the average drug takes 12 years and costs $2.6 billion to bring to market.
That’s why we’ve only invented 500 cures – to treat 10,000 diseases!
This New Breakthrough
Could Mean the
End of Disease!
But what makes this new breakthrough so unique is that it could mean the end of disease for the human species.
And if that sounds like science fiction, consider this –
The largest names in business have invested billions of dollars into this small cap.
Bill Gates owns 7 million shares.
Billionaire hedge-fund manager Steve Cohen owns 1.4 million shares.
BlackRock owns 5 million shares…
Vanguard owns 3 million shares…
And that’s on top of the 5-year partnership agreement they signed with Google.
The list goes on and on…
Never before has medical science moved into a new technology so quickly.
But big business isn’t the only one getting in on the act.
As the true power of this treatment begins to comes into focus, it’s become a national security issue for us and our NATO allies.
And that’s what makes this breakthrough so unique:
It’s not just about money anymore...
It’s about which country is going to lead in the future of medicine for the next fifty years.
That’s why “Bill 117-167” received bi-partisan support and was voted into law on August 9, 2022.
...For us to win the battle for the future, our entire government had to get behind this breakthrough.
This treatment will not just change medicine.
It has the potential to eliminate disease for our species.
And because of that, it could create more millionaires than any other single breakthrough in history. More than the internet, more than computers, more than cars.
The current market capitalization is just $2 billion.
But we expect it to soar to more than twice what Facebook is worth, or $1.5 Trillion, by 2030.
That’s because Wall Street sees the potential of Gilead Sciences.
Early investors in Gilead, one of the pioneers of biological medicine, earned as much as 36,996% on their money.
And that was off the back of one drug Gilead created: Viread. Viread is used to treat HIV patients.
This revolutionary new treatment has the potential to treat all 10,000 diseases, not just one.
In a moment, I’ll take you behind the scenes and share what I know about the breakthrough that’s at the forefront of this medical revolution, and who makes it.
Most importantly, I’ll explain how you can personally profit from it.
Once you see how this technology works you’ll understand why people, companies and governments around the world are rushing to get in on it.
But first, it’s important for you to know who I am and why I am so confident about this unique opportunity.
My Name is Dylan Jovine
My Name is
Dylan Jovine
I started my career on Wall Street in 1991.
That’s when I was hired by Peter Jaquith, one of the investment bankers who became famous for saving New York City from bankruptcy in the 1970s’.
That was a big break for a kid who grew up dirt poor on welfare and food stamps in Queens, New York. I wasn’t going to waste it.
I managed accounts. But I fell in love with researching stocks.
Studying a stock was like reading a short history book about the town the company was in, the people that worked there and the products they made. I loved it. I couldn’t believe people got paid to do this.
Within three years, I earned a reputation for picking stocks right before they were taken over.
Stocks like Paramount which was bought out by Viacom three months after I recommended it for a fast 100% gain.
Or the 70% gains we made when US Reinsurance was acquired six months after I recommended it.
Or the 78% gains we booked when Chase Manhattan Bank was acquired by Chemical Bank.
Or the 83.3% profit we made when Michigan National Bank was acquired for $110.
Remember, this is the early 1990’s - before the internet bull market of the 1990’s.
And here I am this 23-year old kid picking takeover after takeover.
In 1996, my clients bankrolled me to start my own brokerage firm.
And that’s how, at just 24 years old, I became one of the youngest people in American history to launch a start a registered broker-dealer and market maker.
Our offices were at 100 Wall Street, to the right....
I started my career on Wall Street in 1991.
That’s when I was hired by Peter Jaquith, one of the investment bankers who became famous for saving New York City from bankruptcy in the 1970s’.
That was a big break for a kid who grew up dirt poor on welfare and food stamps in Queens, New York. I wasn’t going to waste it.
I managed accounts. But I fell in love with researching stocks.
Studying a stock was like reading a short history book about the town the company was in, the people that worked there and the products they made. I loved it. I couldn’t believe people got paid to do this.
Within three years, I earned a reputation for picking stocks right before they were taken over.
Stocks like Paramount which was bought out by Viacom three months after I recommended it for a fast 100% gain.
Or the 70% gains we made when US Reinsurance was acquired six months after I recommended it.
Or the 78% gains we booked when Chase Manhattan Bank was acquired by Chemical Bank.
Or the 83.3% profit we made when Michigan National Bank was acquired for $110.
Remember, this is the early 1990’s - before the internet bull market of the 1990’s.
And here I am this 23-year old kid picking takeover after takeover.
In 1996, my clients bankrolled me to start my own brokerage firm.
And that’s how, at just 24 years old, I became one of the youngest people in American history to launch a start a registered broker-dealer and market maker.
Our offices were at 100 Wall Street, to the right....
After Predicting the 2009 Market Crash,
I Was Invited onto Fox Business
After Predicting the 2009 Market Crash,
I Was Invited onto Fox Business
Because of what I accomplished at such a young age Wall Street took notice.
But it wasn’t until I predicted the 2008-09 financial crisis and crash a year before it happened that the general public took notice.
Then I was invited onto places like Fox Business News to share my opinion.
My message was simple:
The stock market at 6,500 is like walking into your car dealership when everything is on sale marked 90% off!
Like the 646% returns we booked after buying American Express at $14.24 a share.
Or the 700% in profits with Starbucks which I bought at $8 which then soared to a high of $56.
Or the 459% profits we found buying shares of AutoNation between $10 - $11 a share.
Or the 235% gains that came for those who bought FactSet Research with us at $63.23.
Or John Harland, which was acquired six months after I recommended it, giving investors a 35% gain.
Or shares of K-Swiss, which gave my clients a 65% gain.
And remember Radio Shack? I brought investors 80% profits after the stock soared from $16 to $29.
Or the stellar 40% gains we earned with Hilton, which we bought at $32 before it was acquired for $45.
Now I don’t say all this to brag.
I say it to show you that I've been making money for myself and my clients for close to thirty years. I know what I’m doing.
Because of what I accomplished at such a young age Wall Street took notice.
But it wasn’t until I predicted the 2008-09 financial crisis and crash a year before it happened that the general public took notice.
Then I was invited onto places like Fox Business News to share my opinion.
My message was simple:
The stock market at 6,500 is like walking into your car dealership when everything is on sale marked 90% off!
Like the 646% returns we booked after buying American Express at $14.24 a share.
Or the 700% in profits with Starbucks which I bought at $8 which then soared to a high of $56.
Or the 459% profits we found buying shares of AutoNation between $10 - $11 a share.
Or the 235% gains that came for those who bought FactSet Research with us at $63.23.
Or John Harland, which was acquired six months after I recommended it, giving investors a 35% gain.
Or shares of K-Swiss, which gave my clients a 65% gain.
And remember Radio Shack? I brought investors 80% profits after the stock soared from $16 to $29.
Or the stellar 40% gains we earned with Hilton, which we bought at $32 before it was acquired for $45.
Now I don’t say all this to brag.
I say it to show you that I've been making money for myself and my clients for close to thirty years. I know what I’m doing.
My Love of Biotech is Personal
My Love of Biotech is Personal
And yet - as great as all these gains were, I fully believe this opportunity is fundamentally different.
It’s one of those “once-in-a-generation” kind of opportunities…giving you the chance to earn "once-in-a-generation" profits.
And that brings us to today.
So how does a guy who built his reputation on takeover targets get involved in biotechs?
Right around the time I turned 40 six years ago I was told I had pre-diabetes and high blood pressure. He said to pick my poison – both would kill me if I didn’t get a handle on them.
At first I was shocked. But then I looked in the mirror and I didn’t recognize the face that looked back at me.
Gone was the young man beaming with energy. In his place stood a man pushing 300 lbs with bags under his eyes who had not had a good night sleep in five years.
My wife had just given birth to my first-born daughter Lila and a second one was on the way.
Close to thirty years working 12-hours a day, 7 days a week had taken their toll.
On one hand, I had started, built and sold two separate investment-related companies before I had turned 40: the brokerage firm, which I had sold in 2000, and Tycoon Research.
On the other hand, I was slowly killing myself.
I think we all get to an age when we learn we’re not playing with house money. Well that’s the day I learned I wasn’t.
So in 2013, I sold my last business and decided to take some time off. Get back into balance. Refocus on what’s important…
People said I retired. But once an investor, always an investor.
Only now, because of my health problems, I turned my attention to investing in drug and healthcare companies.
I’ve spent the past 10 years studying the biggest breakthroughs in medicine.
And I’ve decided to do something revolutionary: I’m now allowing people to look "over my shoulder" at my model portfolio so they know exactly what to buy, when to buy and when to sell.
But first let me explain why this opportunity is so unique…and why both big business and government are rushing to seize the opportunity.
And yet - as great as all these gains were, I fully believe this opportunity is fundamentally different.
It’s one of those “once-in-a-generation” kind of opportunities…giving you the chance to earn "once-in-a-generation" profits.
And that brings us to today.
So how does a guy who built his reputation on takeover targets get involved in biotechs?
Right around the time I turned 40 six years ago I was told I had pre-diabetes and high blood pressure. He said to pick my poison – both would kill me if I didn’t get a handle on them.
At first I was shocked. But then I looked in the mirror and I didn’t recognize the face that looked back at me.
Gone was the young man beaming with energy. In his place stood a man pushing 300 lbs with bags under his eyes who had not had a good night sleep in five years.
My wife had just given birth to my first-born daughter Lila and a second one was on the way.
Close to thirty years working 12-hours a day, 7 days a week had taken their toll.
On one hand, I had started, built and sold two separate investment-related companies before I had turned 40: the brokerage firm, which I had sold in 2000, and Tycoon Research.
On the other hand, I was slowly killing myself.
I think we all get to an age when we learn we’re not playing with house money. Well that’s the day I learned I wasn’t.
So in 2013, I sold my last business and decided to take some time off. Get back into balance. Refocus on what’s important…
People said I retired. But once an investor, always an investor.
Only now, because of my health problems, I turned my attention to investing in drug and healthcare companies.
I’ve spent the past 10 years studying the biggest breakthroughs in medicine.
And I’ve decided to do something revolutionary: I’m now allowing people to look "over my shoulder" at my model portfolio so they know exactly what to buy, when to buy and when to sell.
But first let me explain why this opportunity is so unique…and why both big business and government are rushing to seize the opportunity.
Gilead Rose 36,996%
Gilead Rose 36,996%
It’s because this opportunity reminds the smart money of one of the biggest successes in biotech history: Gilead Sciences.
If you were to invest in Gilead Sciences in 1992, you could have seen a 36,996% return on investment.
I think this opportunity could do the same for you without having to invest in options or take unnecessary risk.
"More profound than the discovery of fire."
- Google CEO
But nobody expects it to take 30 years to happen in this case.
Because of the unique power of this breakthrough, and the high-stakes involved, governments are crusading for this medical revolution within the next 5 years.
And because of that, we think one of two things will happen –
A. It either skyrockets like Gilead Sciences, or
B. It’s taken over by a larger competitor.
I know that’s a big claim.
And it should give you pause...
But if you were told just ten years ago that you’d be carrying a device in your pocket as powerful as your home computer, you’d think it was science fiction.
Yet that’s why smart investors are putting more than just their money into this…
That's why Bill Gates wrote an op-ed touting the potential of this discovery on his personal blog.
He's just one of many savvy investors who know how unique this opportunity is.
It’s because this opportunity reminds the smart money of one of the biggest successes in biotech history: Gilead Sciences.
If you were to invest in Gilead Sciences in 1992, you could have seen a 36,996% return on investment.
I think this opportunity could do the same for you without having to invest in options or take unnecessary risk.
"More profound than the discovery of fire."
- Google CEO
But nobody expects it to take 30 years to happen in this case.
Because of the unique power of this breakthrough, and the high-stakes involved, governments are crusading for this medical revolution within the next 5 years.
And because of that, we think one of two things will happen –
A. It either skyrockets like Gilead Sciences, or
B. It’s taken over by a larger competitor.
I know that’s a big claim.
And it should give you pause...
But if you were told just ten years ago that you’d be carrying a device in your pocket as powerful as your home computer, you’d think it was science fiction.
Yet that’s why smart investors are putting more than just their money into this…
That's why Bill Gates wrote an op-ed touting the potential of this discovery on his personal blog.
He's just one of many savvy investors who know how unique this opportunity is.
3 Key Ingredients For Biotech Profits
3 Key Ingredients For Biotech Profits
Before I tell you more about this company, and how to position yourself before mainstream America catches on, I need to let you in on a little secret.
It’s the secret I learned from studying biotech stocks.
You see, most Main Street investors are never taught how to invest in biotech the right way.
One of the things I learned is this: there are 3 Key Ingredients for biotech investment success...
Ingredient #1- Revolutionary Science
The entire drug discovery process is about to change.
That’s why experts predict the industry is about to grow a thousandfold over the next 7 years…
You can’t do that by delivering marginal improvements.
The whole field of medicine has to fundamentally change.
And we’ve never seen anything like this before.
It’s never been possible to invent new drugs in weeks, instead of years.
Of course, the trick is knowing if the underlying science is real and if the patents behind it are valid.
Which brings me to my next criteria…
Ingredient #2- Strong Patent
We don’t want to invest in dreams, we want to invest in science.
Once you have a strong patent it’s like owning a toll bridge.
Everyone who wants to pass by has to pay you a toll.
But without that patent, everyone can steal your idea, as well as all the hard work you put into it.
Which means it’s only a matter of time before you’re out of business.
That’s why owning the rights to this intellectual property is so important.
Ingredient #3- Strategic Partner
You want a partner who takes your breakthrough global by turning a switch.
Remember most biotech companies are started and run by scientists and academics.
What do these guys know about the business of selling drugs around the globe?
That’s why the Bill and Melinda Gates Foundation backing this company is so important.
That’s why this firm’s 5-year partnership agreement with Google is so powerful.
These are just two strategic partnerships that will make a world of difference – and yet, there’s far from the only ones.
This firm’s backers are a real “who’s who” list of Big Pharma money…
The last ingredient is by far the rarest and most special.
You won’t find it with every biotech but when you do you know you’re on the right path.
Again, there are 10,000 diseases that we know of.
And so far, we’ve only developed 500 drugs to deal with them – and those drugs come with significant side effects.
What makes this breakthrough so unique is that it has the potential to cure all of them.
This breakthrough will change medicine and perhaps what it means to be human - I’ve never been more certain of anything in almost thirty years as a professional investor.
So what is this breakthrough that’s going to revolutionize medicine?
How on earth does it have the potential to cure all 10,000 diseases known to science?
In short, it’s a breakthrough that will dramatically change the way we discover new drugs.
It’s called artificial intelligence.
Let me explain....
- CASE STUDY -
How AI is Changing Medicine
We’ve basically been developing drugs the same way since Alexander Fleming discovered penicillin in 1928.
When scientists create a new drug, they test one beaker at a time…
Sometimes they have to wait months to see if their results are any good.
And if they aren’t it’s back to the drawing board.
This is why it costs as much as $2.6 billion dollars to develop a new drug…
Because every single step of the process takes a very long time to test and verify.
But with new breakthroughs in artificial intelligence, it's like having a billion PHD scientists who know every protein and chemical and molecule working at the same time.
This means we can dramatically shorten the time it takes to discover a new drug.
It used to take 10 or 15 years to discover a new drug…
Yet with AI… we’re discovering new potential treatments in as little as 30 days.
"It Created a New Cancer Drug in Only 30 Days"
- The Daily Mail
If that sounds like science fiction, you should know these devices work 100,000 times faster than the human brain.
AI machines never eat, sleep, or take breaks.
And they’re working around the clock to find treatments that we could not possibly find on our own.
Scientists recently used AI to predict who would get pancreatic cancer three whole years before they actually did.
And doctors are now using AI to identify deadly brain tumors in 90 seconds flat – it used to take days to accomplish the same feat.
But these examples are just the tip of the iceberg…
Would take one PhD a BILLION years…
To put this into perspective for you…
It takes a PhD 5 years to identify one protein.
Yet, AI can do the same thing in seconds.
Now, consider this…
There are 200 million human proteins known to science.
AI has created a 3D map of ALL of them.
Scientists estimate it would take a PhD at least a BILLION years to map those 200 million proteins.
AI did it in less than ONE year.
AI machines are using this database of proteins to PREDICT which molecules are likely to respond effectively.
That’s why drug discovery is about to change forever.
We’re about to see a tidal wave of new AI-designed drugs coming to market
Already, there are 420 AI designed treatments that have been approved by the FDA...
And according to MIT Technology Review, there are dozens more entering clinical trials as we speak…
That’s why you almost missed this opportunity – because you are hearing about it just moments before this market explodes.
The diseases you can treat with this approach are limitless.
What AI is doing for these diseases, it can do for any other disease…
Autism
Colon Cancer
Down Syndrome
Parkinson's Disease
Skin Cancer
Tay-Sachs
Breast Cancer
Crohn’s Disease
Hemophilia
Sickle-Cell Disease
These diseases would become
a thing of the past…
Future generations would learn about them by reading about them in the history books.
The New York Times said AI “may change everything”…
Bill Gates said AI was “The most important advance in technology since the user interface.”
Legendary theoretical physicist Stephen Hawking said, “Success in creating AI would be the single biggest event in human history.”
CEO of Google Sundar Pichai said, AI would be “more profound than the discovery of fire, agriculture and electricity.”
Every industry is going all–in on AI — ESPECIALLY Big Pharma.
A recent article by The National Library of Medicine said it best when they said that Big Pharma “craves a big slice” of this technology.
With the stakes so high, you can bet they’re keeping their eyes on AI.
Think about it:
Even if AI cures just 50 diseases in the next few years, as Morgan Stanley is predicting…
That amounts to a brand new $930 billion per year industry at the very minimum…
Which easily could put the leaders of AI drug discovery on the level of Facebook, Google, or Amazon…
Either way, we're at the very beginning of this revolution.
And this is just the beginning of what looks to be a very profitable ride for early investors.
The market for this treatment will grow beyond anything we’re used to.
Artificial Intelligence is about to revolutionize the drug discovery process we’ve relied on for almost 100 years…
So, fasten your seatbelt because things are about to change very quickly.
Before I tell you more about this company, and how to position yourself before mainstream America catches on, I need to let you in on a little secret.
It’s the secret I learned from studying biotech stocks.
You see, most Main Street investors are never taught how to invest in biotech the right way.
One of the things I learned is this: there are 3 Key Ingredients for biotech investment success...
Ingredient #1-
Revolutionary Science
The entire drug discovery process is about to change.
That’s why experts predict the industry is about to grow a thousandfold over the next 7 years…
You can’t do that by delivering marginal improvements.
The whole field of medicine has to fundamentally change.
And we’ve never seen anything like this before.
It’s never been possible to invent new drugs in weeks, instead of years.
Of course, the trick is knowing if the underlying science is real and if the patents behind it are valid.
Which brings me to my next criteria…
Ingredient #2-
Strong Patent
We don’t want to invest in dreams, we want to invest in science.
Once you have a strong patent it’s like owning a toll bridge.
Everyone who wants to pass by has to pay you a toll.
But without that patent, everyone can steal your idea, as well as all the hard work you put into it.
Which means it’s only a matter of time before you’re out of business.
That’s why owning the rights to this intellectual property is so important.
Ingredient #3-
Strategic Partner
You want a partner who takes your breakthrough global by turning a switch.
Remember most biotech companies are started and run by scientists and academics.
What do these guys know about the business of selling drugs around the globe?
That’s why the Bill and Melinda Gates Foundation backing this company is so important.
That’s why this firm’s 5-year partnership agreement with Google is so powerful.
These are just two strategic partnerships that will make a world of difference – and yet, there’s far from the only ones.
This firm’s backers are a real “who’s who” list of Big Pharma money…
The last ingredient is by far the rarest and most special.
You won’t find it with every biotech but when you do you know you’re on the right path.
Again, there are 10,000 diseases that we know of.
And so far, we’ve only developed 500 drugs to deal with them – and those drugs come with significant side effects.
What makes this breakthrough so unique is that it has the potential to cure all of them.
This breakthrough will change medicine and perhaps what it means to be human - I’ve never been more certain of anything in almost thirty years as a professional investor.
So what is this breakthrough that’s going to revolutionize medicine?
How on earth does it have the potential to cure all 10,000 diseases known to science?
In short, it’s a breakthrough that will dramatically change the way we discover new drugs.
It’s called artificial intelligence.
Let me explain....
- CASE STUDY -
How AI is Changing Medicine
We’ve basically been developing drugs the same way since Alexander Fleming discovered penicillin in 1928.
When scientists create a new drug, they test one beaker at a time…
Sometimes they have to wait months to see if their results are any good.
And if they aren’t it’s back to the drawing board.
This is why it costs as much as $2.6 billion dollars to develop a new drug…
Because every single step of the process takes a very long time to test and verify.
But with new breakthroughs in artificial intelligence, it's like having a billion PHD scientists who know every protein and chemical and molecule working at the same time.
This means we can dramatically shorten the time it takes to discover a new drug.
It used to take 10 or 15 years to discover a new drug…
Yet with AI… we’re discovering new potential treatments in as little as 30 days.
"It Created a New Cancer Drug in Only 30 Days."
- The Daily Mail
If that sounds like science fiction, you should know these devices work 100,000 times faster than the human brain.
AI machines never eat, sleep, or take breaks.
And they’re working around the clock to find treatments that we could not possibly find on our own.
Scientists recently used AI to predict who would get pancreatic cancer three whole years before they actually did.
And doctors are now using AI to identify deadly brain tumors in 90 seconds flat – it used to take days to accomplish the same feat.
But these examples are just the tip of the iceberg…
Would take one PhD a BILLION years…
To put this into perspective for you…
It takes a PhD 5 years to identify one protein.
Yet, AI can do the same thing in seconds.
Now, consider this…
There are 200 million human proteins known to science.
AI has created a 3D map of ALL of them.
Scientists estimate it would take a PhD at least a BILLION years to map those 200 million proteins.
AI did it in less than ONE year.
AI machines are using this database of proteins to PREDICT which molecules are likely to respond effectively.
That’s why drug discovery is about to change forever.
We’re about to see a tidal wave of new AI-designed drugs coming to market
Already, there are 420 AI designed treatments that have been approved by the FDA...
And according to MIT Technology Review, there are dozens more entering clinical trials as we speak…
That’s why you almost missed this opportunity – because you are hearing about it just moments before this market explodes.
The diseases you can treat with this approach are limitless.
What AI is doing for these diseases, it can do for any other disease…
Autism
Colon Cancer
Down Syndrome
Parkinson's Disease
Skin Cancer
Tay-Sachs
Breast Cancer
Crohn’s Disease
Hemophilia
Sickle-Cell Disease
These diseases could become
a thing of the past…
Future generations would learn about them by reading about them in the history books.
The New York Times said AI “may change everything”…
Bill Gates said AI was “The most important advance in technology since the user interface.”
Legendary theoretical physicist Stephen Hawking said, “Success in creating AI would be the single biggest event in human history.”
CEO of Google Sundar Pichai said, AI would be “more profound than the discovery of fire, agriculture and electricity.”
Every industry is going all–in on AI — ESPECIALLY Big Pharma.
A recent article by The National Library of Medicine said it best when they said that Big Pharma “craves a big slice” of this technology.
With the stakes so high, you can bet they’re keeping their eyes on AI.
Think about it:
Even if AI cures just 50 diseases in the next few years, as Morgan Stanley is predicting…
That amounts to a brand new $930 billion per year industry at the very minimum…
Which easily could put the leaders of AI drug discovery on the level of Facebook, Google, or Amazon…
Either way, we're at the very beginning of this revolution.
And this is just the beginning of what looks to be a very profitable ride for early investors.
The market for this treatment will grow beyond anything we’re used to.
Artificial Intelligence is about to revolutionize the drug discovery process we’ve relied on for almost 100 years…
So, fasten your seatbelt because things are about to change very quickly.
The Most Profitable
Investments of All Time
The Most
Profitable Investments
of All Time
And that means incredible upside.
Consider the rewards for changing how an entire industry operates, from top to bottom:
Those who invested $1,000 into Microsoft are sitting on $967,000
And that’s the reward facing early investors in AI.
Which is why the biggest, smartest, most informed investors on Wall Street are flocking to invest in this also.
I already mentioned Bill Gates and Google.
The top venture capital firms in the world have invested hundreds of millions in this as well: firms like ARK Investment Management, Credit Suisse, Black Rock, Vanguard, Morgan Stanley, The Bill and Melinda Gates Foundation…
The list goes on and on.
It reads like a who’s who of the smartest VC firms on earth.
It comes down to this…
A person only gets one opportunity in life to invest in something this big this early…and I encourage you to do the same, immediately.
It’s just a matter of time before word gets out and Main Street catches on to what’s really happening here.
By the time that happens it’ll be too late. It's like crypto – one day you never heard of it. The next day everyone on earth is talking about it.
In other words, you want to know about it before your neighbor tells you about it. If your neighbor tells you about it first, you’ll be settling for table scraps.
The time to take action is now.
And at the center of all of this is one small company that owns the patent on this technology - and whose stock could hand investors 5, 10, 20, even 50 times their money.
It could become a BIG WINNER like:
Bluebird which rose 1,336%
American Express which increased 660%
Sagamo Pharma which rose 850%
FactSet Research which gained 235%
AutoNation which soared 420%
Starbucks which moved up 700%
And Sage Therapeutics which shot up 656%
But here’s the thing…
As remarkable as these gains are…
They don’t compare to what’s in front of us right now as we shift toward AI-designed medical treatment.
And while there will be a number of ways to profit in the coming years, there will not be an opportunity like the one before you today.
You see, the dawn of a new medical age is upon us.
This is the very beginning.
One Small Company at the Center of It All
And a remarkable – yet overlooked – company is at the forefront. This company is literally at the center of this medical revolution.
Right now only the savviest scientists and investors know about it. But that’s starting to change.
If you were to make only one investment in the next decade, this is it. It doesn’t get clearer than this.
Of that I have no doubt.
Here are the details…
As I mentioned, artificial intelligence has the opportunity to radically change how we treat diseases.
And the best way to capitalize on this once-in-a-lifetime opportunity is to invest in the small company that made this treatment possible.
Let’s take another look at Gilead Sciences.
And as I mentioned a few minutes ago, early investors made huge gains.
As much as 36,996% on their money.
And that was off the back of one drug Gilead created: Viread. Viread is used to treat HIV patients.
This revolutionary new treatment has the potential to treat all 10,000 diseases, not just one.
That’s why I am confident investors with the foresight to invest in the right companies during the AI revolution will be rewarded with returns similar to these.
And that means incredible upside.
Consider the rewards for changing how an entire industry operates, from top to bottom:
Those who invested $1,000 into Microsoft are sitting on $967,000
And that’s the reward facing early investors in AI.
Which is why the biggest, smartest, most informed investors on Wall Street are flocking to invest in this also.
I already mentioned Bill Gates and Google.
The top venture capital firms in the world have invested hundreds of millions in this as well: firms like ARK Investment Management, Credit Suisse, Black Rock, Vanguard, Morgan Stanley, The Bill and Melinda Gates Foundation…
The list goes on and on.
It reads like a who’s who of the smartest VC firms on earth.
It comes down to this…
A person only gets one opportunity in life to invest in something this big this early…and I encourage you to do the same, immediately.
It’s just a matter of time before word gets out and Main Street catches on to what’s really happening here.
By the time that happens it’ll be too late. It's like crypto – one day you never heard of it. The next day everyone on earth is talking about it.
In other words, you want to know about it before your neighbor tells you about it. If your neighbor tells you about it first, you’ll be settling for table scraps.
The time to take action is now.
And at the center of all of this is one small company that owns the patent on this technology - and whose stock could hand investors 5, 10, 20, even 50 times their money.
It could become a BIG WINNER like:
Bluebird
which rose 1,336%
American Express
which increased 660%
Sagamo Pharma
which rose 850%
FactSet Research
which gained 235%
AutoNation
which soared 420%
Starbucks
which moved up 700%
And Sage Therapeutics
which shot up 656%
But here’s the thing…
As remarkable as these gains are…
They don’t compare to what’s in front of us right now as we shift toward AI-designed medical treatment.
And while there will be a number of ways to profit in the coming years, there will not be an opportunity like the one before you today.
You see, the dawn of a new medical age is upon us.
This is the very beginning.
One Small Company at the Center of It All
And a remarkable – yet overlooked – company is at the forefront. This company is literally at the center of this medical revolution.
Right now only the savviest scientists and investors know about it. But that’s starting to change.
If you were to make only one investment in the next decade, this is it. It doesn’t get clearer than this.
Of that I have no doubt.
Here are the details…
As I mentioned, artificial intelligence has the opportunity to radically change how we treat diseases.
And the best way to capitalize on this once-in-a-lifetime opportunity is to invest in the small company that made this treatment possible.
Let’s take another look at Gilead Sciences.
And as I mentioned a few minutes ago, early investors made huge gains.
As much as 36,996% on their money.
And that was off the back of one drug Gilead created: Viread. Viread is used to treat HIV patients.
This revolutionary new treatment has the potential to treat all 10,000 diseases, not just one.
That’s why I am confident investors with the foresight to invest in the right companies during the AI revolution will be rewarded with returns similar to these.
Either it's Taken Over,
Or it Takes Over the World
Either it's
Taken Over,
Or it Takes
Over the World
But it won’t take 30 years.
The world is moving a lot faster today than it did three decades ago. It will be done in just four. Companies are either taken over or they take over the world.
We are witnessing the launch into an amazing new age of medicine, the likes of which the world has never seen before.
That age, above everything else, is being driven by AI-designed drugs.
AI-designed drugs will literally change your relationship with your doctor.
Imagine not having to take a half-dozen or so different pills every day?
Imagine a world with no side-effects?
That’s literally what we’re talking about here.
It’s no wonder that Scott Gottlieb, former commissioner of the FDA said AI “holds enormous promise for the future of medicine.”
And Prof Kristian Helin, chief executive of The Institute of Cancer Research said “The use of AI promises to have a transformative effect on drug discovery,”
So, to get in on the action, you want to own a company that uses AI to create new drugs.
In the war for the future of medicine you have different sides staking a claim.
Now on one side of the table you have Big Pharma making big bets on this.
For example…
Merck added $17 billion in value when they won the patent in Singapore and China.
Juno Therapeutics was acquired by Celgene ten days after getting some positive results on August 9th.
The list goes on and on…
But here’s the thing…
I’m not recommending any of the big companies.
For the folks who follow my research, I prefer recommending biotechs on the very forefront of this massive change. The biotechs that the large companies are partnering with.
That’s where all the innovation is. And that comes in the form of smaller companies with the world’s leading scientists.
My research has led me to a small AI biotech firm…
And this small company has the patent on the most powerful AI supercomputers.
And they have the two other key ingredients: a strategic partner and they've already survived a patent challenge.
In the last few months, they’ve announced positive results from a partnership with Google and Amazon, one of the largest biotech companies in the world.
Both companies would be natural acquirers.
And even if a small part of the $1.5 trillion market flows toward this small cap firm, the growth will be through the roof.
Amgen made investors 46,750% in part because Medicare pays them $2 billion year for one drug.
As far as opportunities go, we’re comparing apples to oranges here.
To give you an edge, I’ve put all the details in a special report called….
Special Report:
"The End of Disease - The AI Company Revolutionizing Medicine."
Special Report:
"The End of Disease:
The AI Company Revolutionizing Medicine."
This report tells you everything you need to know about this incredible company --- and why the world’s leading scientist believes its AI technology is the best, giving you the chance for a 36,996% return.
I will give it to you for free at the end of this letter.
Again, the AI revolution is in its infancy. Most people I talk to have never even heard of it - yet.
Which is why the smart money is pouring so much into this idea. By the time your neighbor is talking about it, it’s going to be too late.
So even if this handles just one disease, like Amgen, you can see its stock rise to 36,996%.
And this is the company best position to capture the bulk of the upside.
I have no doubt, if you invest in this company today, you give yourself the opportunity to make the kind of money that lets you put your name on a building.
There is no time to waste. The biggest obstacle preventing this stock from returning 36,996% is that it gets acquired by one of the major pharma companies it has deals with.
Again, my report "The End of Disease - The AI Company Revolutionizing Medicine." is yours absolutely free.
Nobody is Even Talking About it Yet
I want you to have these three reports for free because, to be perfectly frank, there isn’t one credible source covering these AI stocks. Not one.
The biggest story in medicine by far– truly the very definition of a revolution – and I haven’t seen one credible source telling investors how to profit from this. It’s mind-boggling.
That’s actually what got me into this in the first place.
You see, it wasn't my intention to build a network of doctors and scientists.
Remember, I told you that because I was sick for the first time in my life I became interested in biotech investing?
Well there I am retired looking for some guidance so I could invest my money in biotech stocks.
You know what happened?
I struck out. I literally couldn’t find good newsletters or other sources to follow. My only option was to invest seven figures in a biotech hedge-fund.
Well since I was retired and had the time I started doing the legwork. Good old-fashioned research. Calling people, speaking with doctors, asking scientists, you name it I did it.
Then I heard about three stocks: LCI, INO, PBYI. I read about them from serious scientists, not stock promoters. And they believe the science is real.
First I read about Inovio Pharma and I proceed to watch the stock soar 610% within 13 months.
But I’ve worked on Wall Street and been in the game for almost thirty years. I’ve heard every hustle in the book.
So I’m skeptical. Anyone can get lucky.
Then I read about another stock, Puma Biotechnology, which shoots up 452% in twelve months.
And mind you they seem to be the only people on earth talking about these.
I’m looked everywhere else – and believe me I know where to look – and came up empty.
And then finally, after Lannett soars 1,260% in two years I think to myself there's something special happening in biotech.
You know how much money I made with these three stocks?
Not a single penny. And that hurt. It always hurts to know about big gains you could have made but didn’t.
But I wasn’t skeptical any more. I felt like I was watching a secret bull market in biotech.
And it’s that experience that has lead me start an investment advisory service called Behind the Markets.
This investment service allows you to look over my shoulder at what I’m buying and selling each and every single month. Basically, I’m sharing my rolodex of scientists and doctors with you.
As soon as you become a member of Behind the Markets, you become part of my “inner circle” – just like my mother – and you’ll get access to every single investment opportunity I discover each month.
As a member of Behind the Markets you’ll receive:
- Access to my model portfolio…I typically recommend one new stock a month, or 12 new stocks a year. By getting access to my model portfolio you’ll know what to buy, at what price to buy it and exactly when to sell it. To be clear…the portfolio will not just focus on biotech stocks. I focus on all areas of the market. If there is a chance to buy a stock for less than its worth, we take advantage of it.
- Regular updates…Whenever there is any news on one of our portfolio companies you’ll get an email from me by the end of the day, at the latest. I don’t hide under my desk.
- 24/7 access to my website. I keep all my latest information on an encrypted website that members can access at anytime, anywhere.
But most importantly, once you join Behind the Markets, you get access to yours truly – me.
Like my own family and friends, from now on you’ll know about the big opportunities like this AI stock early, when the rest of the smart money learns about them. By the time the general public starts buying shares, it will be us selling our stock to them.
You’ll also know EXACTLY what to buy or what to sell or what to do when the market crashes, like it did in 2009.
The AI at the forefront of the revolution will give you the opportunity to own the next Gilead, and earn life-changing profits.
I don’t want anything to hold you back from what’s at hand.
Helping you achieve immense wealth is my new mission. And it brings me great joy to know that I can help others do that as well.
In short, you get to access a brain that has made millions for myself and for other people during the past three decades.
Which is why I’ve kept the cost of Behind the Markets at the lowest possible level.
However, I am a businessman so I’m not going to make an offer that makes me lose money making this offer to you. That’s why I’m offering you this service for the same amount it costs my business to get this to you.
Just $49.
And frankly, I believe it’s a steal at that price.
That’s less than what it cost my wife and I to eat dinner last night at Applebees. We don’t drink.
That means I’m going to lose $160 on each and every order.
The plan is that you get so much out of Behind the Markets that you stay a loyal customer forever.
Plus, the three special reports I’ve promised you today are worth $99 each for a total of $297 by themselves.
But more importantly, it’s the opportunity to own a piece of a business that could make investors 100,000% on their money.
Assuming it’s not taken over for a 100% gain first. I don’t know about you, but I’ve been around long enough to know how rare that is.
Look:
As I mentioned earlier, this is about feeding more than my wallet. It’s about feeding my soul. And the best way for me to do that is to help as many people as I can.
And I grew up on welfare and food stamps. So I will never forget the value of a dollar.
Introductory Offer
Introductory Offer
And finally, just to prove how confident I am, let me remove any last shred of doubt about this investment.
Try Behind the Markets risk-free for 30 days. Take the month to review my service and I. Take a hard look at our open positions.
If I do not meet or exceed your expectations, just call customer service and you’ll get a 100% full refund. No questions asked.
PLUS, you can keep the free reports you get today.
Join me while we ride this medical revolution. Sign up for Behind the Markets and let me share with you what it is I do best each month, just like I do with my friends and family.
I promise you to do my best to honor the name of this service by taking you behind the daily markets and showing you profit opportunities before the rest of the world finds out about them.
Thank you so much for reading this important presentation.
I sincerely hope you’ll take me up on this offer.
I’m confident you’ll look back one day and think that joining Behind the Markets was one of the best financial moves you ever made.
But there’s something else I want to pass on to you.
Something that may prove to be as valuable to you as any profitable trade we make together:
- Your Free Bonus Report #1: “The End of Disease - The AI Company Revolutionizing Medicine" (Value: $297)
This report gives you all the details on the amazing company we discussed today.
You’ll learn the name of the company, its stock symbol and why so many of the world’s leading scientists believe its AI technology is the best.
Just this report alone gives you the chance to earn life-changing profits.
- Your Free Bonus Report #2: Bullet-Proof: How to Create the Ideal Small Cap Biotech Stock Portfolio (Value: $197)
While FANG stocks have been getting all the attention of late, individual investors seem to have forgotten all about the biotech stocks.
In this report we show you exactly how to contrast a bullet-proof biotech portfolio with tremendous upside… … an opportunity, my friend, that could make you filthy rich.
But the time you finish this report, you’ll be well on your way to earning life-changing profits in biotech. - Your Free Bonus #3: Medical Money: How to Generate Monthly Income from Your Biotech Portfolio (Value: $199)
The best thing about investing in biotech stocks is that some come with a hidden mechanism that allow you to generate both profits and income.
This report will show you step-by-step exactly how to find the biotech stocks that are primed to give you the biggest upside opportunity – and the most income at the same time. - Your Free Bonus Report #4: 3 Ingredients to Biotech Profits (Value: $179)
Learn for yourself how to pick great biotech investments with this simple, yet disciplined, method of identifying the best biologics on the market.
This brief guide will completely familiarize you with the basic concepts behind picking great biologics, and will highlight some of the benefits you’ll see from using them when you trade. - Your Free Bonus #5: Tidal Wave: How the Medical Revolution Will Change Your Relationship with Your Doctor (Value: $197)
Want to learn how the world’s best biotech companies are changing the world of medicine as we know it?
Go behind the scenes for an in-depth look at how prostate cancer is being treated with the next generation of medicines.
This report will show you step-by-step exactly how new biologic treatments are making the old chemical treatments a thing of the past…and how you can profit from that.
- Your Free Bonus Report #6: Pot Stock Profits: What the History of Cigarettes Can Show Us About Making Money With Cannabis (Value: $249)
Cannabis stocks are all the rage. But cannabis isn’t the first plant to become a best-selling consumer product in this country.
What lessons does the history of the tobacco industry offer cannabis investors?
In this breakthrough report, we take a look at all the lessons the rise of cigarette companies can teach investors. By the time you finish this report you’ll know which marijuana segments are most likely to succeed and why.
- Your Free Bonus Report #7: 6 Questions to Ask Before Buying Any Stock (Value: $179)
Pretty soon, it will seem like everybody is talking about AI and the drug discovery revolution in general and how much money is going to be made.
And while I don’t doubt that’s true, I’ve been around long enough to know that with every legitimate profit opportunity they’re will be hustlers trying to take advantage of it. Bernie Madoff, Worldcom and Enron come to mind.
Well, the AI is no different. There will be massive winners – companies like the ones I’ve described to you today. dogs. Companies that talk a good game and promise the world, but that don’t have the infrastructure, technology or management in place to deliver.
This report will show you how to pick the next big winners – and avoid the big losers.
Let me quickly recap what you can expect from
Behind the Markets…
1. Unmatched Advice, Winning Recommendations: You’ll get the benefit of the best investment experience money can buy in 12 monthly issues of Behind the Markets – e-mailed directly to your inbox. Once you get the email, simply call your broker or place your trade online. Value: $199
2. 7 FREE Bonus Reports: You’ll get seven invaluable free bonus reports right away, as soon as you join. Even if you cancel, they are yours to keep! Value: $1,497
3. 100% Money-Back Guarantee: Because I want you to profit from my advice without fear and without hesitation, I’m backing up my claims with an unconditional guarantee: Try Behind the Markets risk free. If you don’t like the service in the first 30 days for any reason whatsoever, every dime you paid toward your membership will be returned to you. The reports are yours to keep. Total Value: $1,696!
All available for the low price today of just $49.
A Rare Opportunity
A Rare Opportunity
That’s because I know this AI revolution is about to create as many new millionaires as the Internet did for the tech industry…and I want you to be among the few who have the opportunity to make the kind of money that can change the way you live your life.
And it starts with one biotech company at the center of it all.
Those who get in now, on the ground floor, could see the kind of returns Amgen investors saw.
Remember, investors in Amgen turned every $1,000 into $47 million on the back of just one drug, Epogen. I believe this company has that kind of potential.
But you need to act fast. The biggest risk on the positive side of the equation is that this company gets taken over too soon.
Just click on the button below to get started.
This one-in-a-lifetime opportunity is yours for the taking.
I urge you to take advantage of it today.
I look forward to having you on board.
Sincerely,
That’s because I know this AI revolution is about to create as many new millionaires as the Internet did for the tech industry…and I want you to be among the few who have the opportunity to make the kind of money that can change the way you live your life.
And it starts with one biotech company at the center of it all.
Those who get in now, on the ground floor, could see the kind of returns Amgen investors saw.
Remember, investors in Amgen turned every $1,000 into $47 million on the back of just one drug, Epogen. I believe this company has that kind of potential.
But you need to act fast. The biggest risk on the positive side of the equation is that this company gets taken over too soon.
Just click on the button below to get started.
This one-in-a-lifetime opportunity is yours for the taking.
I urge you to take advantage of it today.
I look forward to having you on board.
Sincerely,